These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 11076725)
1. Meningococcemia in a patient coinfected with hepatitis C virus and HIV. Nelson CG; Iler MA; Woods CW; Bartlett JA; Fowler VG Emerg Infect Dis; 2000; 6(6):646-8. PubMed ID: 11076725 [TBL] [Abstract][Full Text] [Related]
2. Chronic meningococcemia in a child with a deficiency of the sixth component of complement. Fasano MB; Sullivan K; Ibsen L; Winkelstein JA Pediatr Allergy Immunol; 1993 Nov; 4(4):214-6. PubMed ID: 8298713 [TBL] [Abstract][Full Text] [Related]
4. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center. Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421 [TBL] [Abstract][Full Text] [Related]
5. [Chronic meningococcemia--a rare prolonged infection and disturbance in the function of complement]. Nieminen U Duodecim; 1991; 107(5):354-7. PubMed ID: 1364465 [No Abstract] [Full Text] [Related]
6. Elevated plasma concentrations of protease inhibitors and nonnucleoside reverse transcriptase inhibitors in patients coinfected with human immunodeficiency virus and hepatitis B or C: case series and literature review. Robertson SM; Scarsi KK; Postelnick MJ; Lynch P Pharmacotherapy; 2005 Aug; 25(8):1068-72. PubMed ID: 16207097 [TBL] [Abstract][Full Text] [Related]
7. Characteristics and treatment of hepatitis C virus infection in HIV-coinfected subjects. Zylberberg H; Pol S AIDS Patient Care STDS; 1998 Jan; 12(1):11-9. PubMed ID: 11361880 [TBL] [Abstract][Full Text] [Related]
8. Low levels of hepatitis C virus (HCV) neutralizing antibodies in patients coinfected with HCV and human immunodeficiency virus. Castelain S; Schnuriger A; François C; Nguyen-Khac E; Fournier C; Schmit JL; Capron D; Dubuisson J; Wychowski C; Thibault V; Duverlie G J Infect Dis; 2008 Aug; 198(3):332-5. PubMed ID: 18558868 [TBL] [Abstract][Full Text] [Related]
9. [Hepatitis C virus infection in HIV coinfected patients]. Berenguer J Rev Clin Esp; 2010; 210(7):338-41. PubMed ID: 20609839 [No Abstract] [Full Text] [Related]
10. Hepatic steatosis in HIV/hepatitis C coinfection: prevalence and significance compared with hepatitis C monoinfection. Monto A; Dove LM; Bostrom A; Kakar S; Tien PC; Wright TL Hepatology; 2005 Aug; 42(2):310-6. PubMed ID: 16025515 [TBL] [Abstract][Full Text] [Related]
11. [Acute meningococcemia in a 4-month-old infant]. Topalović R; Bauman S Med Pregl; 2000; 53(7-8):401-4. PubMed ID: 11214486 [TBL] [Abstract][Full Text] [Related]
12. Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus. Marks KM; Petrovic LM; Talal AH; Murray MP; Gulick RM; Glesby MJ J Infect Dis; 2005 Dec; 192(11):1943-9. PubMed ID: 16267765 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis C and B viruses: the new opportunists in HIV infection. Chung RT Top HIV Med; 2006; 14(2):78-83. PubMed ID: 16835462 [TBL] [Abstract][Full Text] [Related]
14. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users. Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP; Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472 [TBL] [Abstract][Full Text] [Related]
15. Tri-infection: successful treatment of a patient infected with HIV and hepatitis B and C viruses--a case report. Johanson F AIDS Read; 2004 Jul; 14(7):389-94. PubMed ID: 15282868 [TBL] [Abstract][Full Text] [Related]
16. Porphyria cutanea tarda and human immunodeficiency virus: two cases associated with hepatitis C. O'Connor WJ; Badley AD; Dicken CH; Murphy GM Mayo Clin Proc; 1998 Sep; 73(9):895-7. PubMed ID: 9737229 [TBL] [Abstract][Full Text] [Related]
17. Lopinavir/ritonavir pharmacokinetics, efficacy, and safety in HIV and hepatitis B or C coinfected adults without symptoms of hepatic impairment. Khaykin P; Kotzerke P; Stephan C; Nisius G; Bickel M; Haberl A; Stürmer M; Kurowski M; Brodt R; von Hentig N Ther Drug Monit; 2014 Apr; 36(2):192-201. PubMed ID: 24632753 [TBL] [Abstract][Full Text] [Related]
18. The role of hepatitis C virus (HCV) in mitochondrial DNA damage in HIV/HCV-coinfected individuals. de Mendoza C; Soriano V Antivir Ther; 2005; 10 Suppl 2():M109-15. PubMed ID: 16152712 [TBL] [Abstract][Full Text] [Related]
19. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001. Giordano TP; Kramer JR; Souchek J; Richardson P; El-Serag HB Arch Intern Med; 2004 Nov; 164(21):2349-54. PubMed ID: 15557414 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus (HCV) protease variability and anti-HCV protease inhibitor resistance in HIV/HCV-coinfected patients. Trimoulet P; Belzunce C; Faure M; Wittkop L; Reigadas S; Dupon M; Ragnaud JM; Fleury H; Neau D HIV Med; 2011 Sep; 12(8):506-9. PubMed ID: 21410862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]